Effect of high-dose dexamethasone on patients without diabetes during elective neurosurgery: a prospective study.

Published in: Diabetology international (2018)

The use of high-dose dexamethasone in this cohort of neurosurgical patients did not result in glucocorticoid-induced diabetes. Hyperglycaemia was transient and had resolved by 6 weeks.

Keyphrases

high dose
end stage renal disease
low dose
type diabetes
newly diagnosed
ejection fraction
chronic kidney disease
cardiovascular disease
prognostic factors
stem cell transplantation
patients undergoing
adipose tissue
high glucose
patient reported
endothelial cells
brain injury